A Multicenter, Open Label Study of Oral Melphalan, Prednisone, and CC-5013 (Revlimid) (MPR) as Induction Therapy in Elderly Newly Diagnosed Multiple Myeloma Patients
Phase of Trial: Phase I/II
Latest Information Update: 04 Jun 2009
At a glance
- Drugs Lenalidomide (Primary) ; Melphalan (Primary) ; Prednisone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 04 Jun 2009 New trial record.